These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10600648)

  • 1. The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers.
    Pariat M; Salvat C; Bébien M; Brockly F; Altieri E; Carillo S; Jariel-Encontre I; Piechaczyk M
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):129-38. PubMed ID: 10600648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of FOS and JUN family members to calpains.
    Carillo S; Pariat M; Steff AM; Roux P; Etienne-Julan M; Lorca T; Piechaczyk M
    Oncogene; 1994 Jun; 9(6):1679-89. PubMed ID: 8183563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility.
    Stabach PR; Cianci CD; Glantz SB; Zhang Z; Morrow JS
    Biochemistry; 1997 Jan; 36(1):57-65. PubMed ID: 8993318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The designed protein M(II)-Gly-Lys-His-Fos(138-211) specifically cleaves the AP-1 binding site containing DNA.
    Harford C; Narindrasorasak S; Sarkar B
    Biochemistry; 1996 Apr; 35(14):4271-8. PubMed ID: 8605175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA.
    Glover JN; Harrison SC
    Nature; 1995 Jan; 373(6511):257-61. PubMed ID: 7816143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts.
    Steff AM; Carillo S; Pariat M; Piechaczyk M
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):685-92. PubMed ID: 9169601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex.
    Mo Y; Ho W; Johnston K; Marmorstein R
    J Mol Biol; 2001 Nov; 314(3):495-506. PubMed ID: 11846562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of ATP-sensitive potassium channels prevents the cleavage of cytosolic mu-calpain and abrogates the elevation of nuclear c-Fos and c-Jun expressions after hypoxic-ischemia in neonatal rat brain.
    Jiang KW; Yu ZS; Shui QX; Xia ZZ
    Brain Res Mol Brain Res; 2005 Jan; 133(1):87-94. PubMed ID: 15661368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein.
    Carillo S; Pariat M; Steff Am; Jariel-Encontre I; Poulat F; Berta P; Piechaczyk M
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):245-51. PubMed ID: 8546691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
    Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
    Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
    Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
    Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription. Zen and the art of Fos and Jun.
    Kerppola T; Curran T
    Nature; 1995 Jan; 373(6511):199-200. PubMed ID: 7816132
    [No Abstract]   [Full Text] [Related]  

  • 17. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA bending determines Fos-Jun heterodimer orientation.
    Leonard DA; Kerppola TK
    Nat Struct Biol; 1998 Oct; 5(10):877-81. PubMed ID: 9783746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immediate-early oncoproteins Fra-1, c-Fos, and c-Jun have distinguishable surface behavior and interactions with phospholipids.
    Gaggiotti MC; Del Boca M; Castro G; Caputto BL; Borioli GA
    Biopolymers; 2009 Sep; 91(9):710-8. PubMed ID: 19384981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.